世界の慢性不応性咳嗽(CRC)治療市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Chronic Refractory Cough (CRC) Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP13118)・商品コード:GIR20SP13118
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月25日(※2024年版があります。お問い合わせください)
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、慢性不応性咳嗽(CRC)治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性不応性咳嗽(CRC)治療の種類別市場規模(言語療法、理学療法)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Attenua、Nerre Therapeutics、Bellus Health、Shionogi、Respivant Sciences
・地域別グローバル市場分析 2015年-2020年
・慢性不応性咳嗽(CRC)治療の北米市場(アメリカ、カナダ、メキシコ)
・慢性不応性咳嗽(CRC)治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・慢性不応性咳嗽(CRC)治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・慢性不応性咳嗽(CRC)治療の南米市場(ブラジル、アルゼンチン)
・慢性不応性咳嗽(CRC)治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:言語療法、理学療法
・用途別分析:病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Chronic Refractory Cough (CRC) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Chronic Refractory Cough (CRC) Treatment sales will be xx in 2020 from Chronic Refractory Cough (CRC) Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Chronic Refractory Cough (CRC) Treatment market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Chronic Refractory Cough (CRC) Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Chronic Refractory Cough (CRC) Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Chronic Refractory Cough (CRC) Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Chronic Refractory Cough (CRC) Treatment market has been segmented into:
Speech Therapy
Physiotherapy

By Application, Chronic Refractory Cough (CRC) Treatment has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Refractory Cough (CRC) Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Refractory Cough (CRC) Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Refractory Cough (CRC) Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Chronic Refractory Cough (CRC) Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Chronic Refractory Cough (CRC) Treatment Market Share Analysis
Chronic Refractory Cough (CRC) Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Refractory Cough (CRC) Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Refractory Cough (CRC) Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Chronic Refractory Cough (CRC) Treatment are:
Merck
Attenua
Nerre Therapeutics
Bellus Health
Shionogi
Respivant Sciences
Among other players domestic and global, Chronic Refractory Cough (CRC) Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Chronic Refractory Cough (CRC) Treatment Market Overview
1.1 Product Overview and Scope of Chronic Refractory Cough (CRC) Treatment
1.2 Classification of Chronic Refractory Cough (CRC) Treatment by Type
1.2.1 Global Chronic Refractory Cough (CRC) Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type in 2019
1.2.3 Speech Therapy
1.2.4 Physiotherapy
1.3 Global Chronic Refractory Cough (CRC) Treatment Market by Application
1.3.1 Overview: Global Chronic Refractory Cough (CRC) Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chronic Refractory Cough (CRC) Treatment Market by Regions
1.4.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chronic Refractory Cough (CRC) Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chronic Refractory Cough (CRC) Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chronic Refractory Cough (CRC) Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Refractory Cough (CRC) Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chronic Refractory Cough (CRC) Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Refractory Cough (CRC) Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Chronic Refractory Cough (CRC) Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Chronic Refractory Cough (CRC) Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Chronic Refractory Cough (CRC) Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Attenua
2.2.1 Attenua Details
2.2.2 Attenua Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Attenua SWOT Analysis
2.2.4 Attenua Product and Services
2.2.5 Attenua Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nerre Therapeutics
2.3.1 Nerre Therapeutics Details
2.3.2 Nerre Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nerre Therapeutics SWOT Analysis
2.3.4 Nerre Therapeutics Product and Services
2.3.5 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bellus Health
2.4.1 Bellus Health Details
2.4.2 Bellus Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bellus Health SWOT Analysis
2.4.4 Bellus Health Product and Services
2.4.5 Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shionogi
2.5.1 Shionogi Details
2.5.2 Shionogi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shionogi SWOT Analysis
2.5.4 Shionogi Product and Services
2.5.5 Shionogi Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Respivant Sciences
2.6.1 Respivant Sciences Details
2.6.2 Respivant Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Respivant Sciences SWOT Analysis
2.6.4 Respivant Sciences Product and Services
2.6.5 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chronic Refractory Cough (CRC) Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Refractory Cough (CRC) Treatment Players Market Share
3.2.2 Top 10 Chronic Refractory Cough (CRC) Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chronic Refractory Cough (CRC) Treatment Revenue and Market Share by Regions
4.2 North America Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
5 North America Chronic Refractory Cough (CRC) Treatment Revenue by Countries
5.1 North America Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
5.2 USA Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
6 Europe Chronic Refractory Cough (CRC) Treatment Revenue by Countries
6.1 Europe Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
6.2 Germany Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
6.4 France Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue by Countries
7.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
7.2 China Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
7.5 India Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
8 South America Chronic Refractory Cough (CRC) Treatment Revenue by Countries
8.1 South America Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
8.2 Brazil Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chronic Refractory Cough (CRC) Treatment by Countries
9.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chronic Refractory Cough (CRC) Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Chronic Refractory Cough (CRC) Treatment Market Forecast by Type (2019-2024)
10.3 Speech Therapy Revenue Growth Rate (2015-2025)
10.4 Physiotherapy Revenue Growth Rate (2015-2025)
11 Global Chronic Refractory Cough (CRC) Treatment Market Segment by Application
11.1 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2015-2020)
11.2 Chronic Refractory Cough (CRC) Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Chronic Refractory Cough (CRC) Treatment Market Size Forecast (2021-2025)
12.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Forecast (2021-2025)
12.2 Global Chronic Refractory Cough (CRC) Treatment Market Forecast by Regions (2021-2025)
12.3 North America Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
12.6 South America Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Chronic Refractory Cough (CRC) Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Refractory Cough (CRC) Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Refractory Cough (CRC) Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Chronic Refractory Cough (CRC) Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck Corporate Information, Location and Competitors
Table 7. Merck Chronic Refractory Cough (CRC) Treatment Major Business
Table 8. Merck Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Merck SWOT Analysis
Table 10. Merck Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 11. Merck Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Attenua Corporate Information, Location and Competitors
Table 13. Attenua Chronic Refractory Cough (CRC) Treatment Major Business
Table 14. Attenua Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Attenua SWOT Analysis
Table 16. Attenua Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 17. Attenua Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Nerre Therapeutics Corporate Information, Location and Competitors
Table 19. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Major Business
Table 20. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Nerre Therapeutics SWOT Analysis
Table 22. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 23. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bellus Health Corporate Information, Location and Competitors
Table 25. Bellus Health Chronic Refractory Cough (CRC) Treatment Major Business
Table 26. Bellus Health Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Bellus Health SWOT Analysis
Table 28. Bellus Health Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 29. Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Shionogi Corporate Information, Location and Competitors
Table 31. Shionogi Chronic Refractory Cough (CRC) Treatment Major Business
Table 32. Shionogi Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Shionogi SWOT Analysis
Table 34. Shionogi Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 35. Shionogi Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Respivant Sciences Corporate Information, Location and Competitors
Table 37. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Major Business
Table 38. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Respivant Sciences SWOT Analysis
Table 40. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product and Solutions
Table 41. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Players (2015-2020)
Table 43. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Players (2015-2020)
Table 44. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Regions (2015-2020)
Table 46. North America Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
Table 47. North America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Europe Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Chronic Refractory Cough (CRC) Treatment Revenue by Countries (2015-2020)
Table 51. South America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Table 54. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) by Type (2015-2020)
Table 55. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Type (2015-2020)
Table 56. Global Chronic Refractory Cough (CRC) Treatment Revenue Forecast by Type (2021-2025)
Table 57. Global Chronic Refractory Cough (CRC) Treatment Revenue by Application (2015-2020)
Table 58. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Application (2015-2020)
Table 59. Global Chronic Refractory Cough (CRC) Treatment Revenue Forecast by Application (2021-2025)
Table 60. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chronic Refractory Cough (CRC) Treatment Picture
Figure 2. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type in 2019
Figure 3. Speech Therapy Picture
Figure 4. Physiotherapy Picture
Figure 5. Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Chronic Refractory Cough (CRC) Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Chronic Refractory Cough (CRC) Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Chronic Refractory Cough (CRC) Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries in 2019
Figure 42. China Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Chronic Refractory Cough (CRC) Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Type in 2019
Figure 59. Global Chronic Refractory Cough (CRC) Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Speech Therapy Revenue Growth Rate (2015-2020)
Figure 61. Global Physiotherapy Revenue Growth Rate (2015-2020)
Figure 62. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Chronic Refractory Cough (CRC) Treatment Revenue Share by Application in 2019
Figure 64. Global Chronic Refractory Cough (CRC) Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Chronic Refractory Cough (CRC) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Chronic Refractory Cough (CRC) Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Merck、Attenua、Nerre Therapeutics、Bellus Health、Shionogi、Respivant Sciences

★調査レポート[世界の慢性不応性咳嗽(CRC)治療市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP13118)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の慢性不応性咳嗽(CRC)治療市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆